Bajaj ConsumerQ4 FY25

Bajaj Consumer Q4 FY25 Earnings Call Analysis

Revenue, margin, capex, fundraise and order book outlook from management commentary.

Price: ₹447.05P/E: 23.3Market Cap: ₹5.8K CrSector: Personal Products

Management growth scorecard

Revenue

Category 4

Margin

Category 1

Fundraise

N/A

Order

N/A

Capex

Yes

2 of 3 growth signals are positive.

Full analysis

Revenue guidance

Category 4
  • The company anticipates strong growth in coming quarters driven by improved market conditions and capability building efforts.
  • Almond Drops Hair Oil (ADHO), the core brand, is expected to recover and see meaningful growth, especially as general trade and distribution improve.
  • Banjara’s acquisition is projected to contribute significantly, with expectations to surpass FY25 sales of Rs. 53 crores, primarily impacting Q2, Q3, and Q4 of FY26.
  • The international business demonstrates robust growth with a 26% annual increase and strong quarter-on-quarter traction, expected to continue.
  • E-commerce and modern trade channels show consistent growth, with efforts to expand reach and distribution through Project Aarohan underway.
  • New product developments (NPDs) like Almond Drops Hair and Skin Care range and coconut oil are growing strongly and expected to scale further.
  • Overall, the company is confident of moving "one or two notches higher" in performance and achieving higher topline and EBITDA margin improvements going forward.

See what Bajaj Consumer management said on margin guidance — free account, 30 seconds.

Fundraise plans

- The transcript from Bajaj Consumer Care Limited's Q4 FY’25 earnings call does not explicitly mention any current or future plans for fundraising through debt or equity. - No specific guidance or statements regarding raising capital via debt or equity instruments were provided by management. - The focus of the management commentary was primarily on strengthening operations, capacity building, integration of acquisitions, growth strategies, cost rationalizations, and margin improvements. - There is no indication of ongoing or planned fundraising activities as part of their strategic initiatives in the document. - Any funding for acquisitions, like that of Banjara’s, appears to be in the process of completion without explicit mention of fresh debt or equity issuance. In summary, no current or future fundraising through debt or equity has been disclosed in the provided transcript.

See what Bajaj Consumer management said on order book — free account, 30 seconds.

Capex plans

Yes
- Bajaj Consumer Care is engaged in multiple capability-building exercises, aiming to enhance its multifaceted organization with multiple products, channels, and geographies to strengthen the company. - The acquisition of Banjara’s is a strategic investment; Bajaj aims to complete 100% acquisition by Q1 FY26, making it a wholly owned subsidiary. - There is an ongoing post-merger integration project with a leading consultant to streamline operations, expected to complete within 8-12 weeks from April 2025. - Project Aarohan (RTM revamp) is being expanded to new states to enhance distribution and market reach, with Phase-II implementation expected by May 2025. - Marketing investments continue, notably for brands like Bajaj 100% Pure Coconut Oil, including launches of new packs and digital marketing campaigns. - The company has undertaken automation and smart manufacturing initiatives to improve productivity and reduce costs, indirectly representing investment in capex to support growth. No explicit future large-scale capex figures were provided, but strategic investments focus on acquisitions, distribution expansion, and capability enhancements.

Track Bajaj Consumer — get its next earnings analysis in your feed

How does Bajaj Consumer rank vs peers in Personal Products?

Pro feature
ThisBajaj Consumer
Rev 4Mar 1

How does Bajaj Consumer rank in Personal Products?

Compare Bajaj Consumer against every Personal Products company (Q4 FY25) on revenue, margins and earnings-call signals.

View Personal Products leaderboard →

Others in Personal Products this season

  • Anondita Medicare Ltd (Q3 FY26)

    Revenue from operations (Standalone) for H1 FY26: ₹4,765.06 lakh; H1 FY25: ₹2,497.06 lakh; YoY growth: 91% (Page 26) . Key investor presentation takeaways from

  • Anondita Medicare Ltd (Q4 FY26)

    Current unexecuted order book stands at approximately INR137 crores, which remains intact from the previous year. Key concall takeaways from Anondita Medicare…

  • Cupid Ltd (Q4 FY24)

    6,289 Lakhs, up 57.04% QoQ and 51.59% YoY from Rs. Key concall takeaways from Cupid Ltd's Q4 FY24 earnings call — and how it ranks against sector peers.

  • Cupid Ltd (Q1 FY25)

    Total Income (₹ in Lakhs): . Key concall takeaways from Cupid Ltd's Q1 FY25 earnings call — and how it ranks against sector peers.

🔎 Who's planning the most growth?

Companies ranked by management's own guidance — revenue, margins, capex and order book, from every earnings call in India.

See rankings →